Carcinotech selected to join the Converge 2019 Cohort

close up image

A human skin culture system that mimics human skin and replaces animal testing; an interactive map to help blind and visually impaired people to navigate safely around train stations and a flat-pack, solar collector offering affordable, clean energy for developing countries – these are just some of the trail-blazing ideas emerging from the pool of 2019 Converge participants. Carcinotech is one of the semi-finalists to join the Converge Cohort 2019.

Read the full article here

Related Posts

About Us

Carcinotech is a MedTech company with expertise in manufacturing 3D printed living tumours using patient-derived biopsies, primary cells, immune cells and cancer stem cells.

Let’s Socialize

Popular Post